Mihaela Tudor
Overview
Explore the profile of Mihaela Tudor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben Diouf O, Gilbert A, Bernay B, Syljuasen R, Tudor M, Temelie M, et al.
Proteomes
. 2025 Jan;
13(1.
PMID: 39846632
Glioblastoma (GBM) is a devastating malignant brain tumor with a poor prognosis. GBM is associated with radioresistance. Post-translational modifications (PTMs) such as protein phosphorylation can play an important role in...
2.
Tudor M, Popescu R, Irimescu I, Rzyanina A, Tarba N, Dinischiotu A, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519034
To overcome chondrosarcoma's (CHS) high chemo- and radioresistance, we used polyethylene glycol-encapsulated iron oxide nanoparticles (IONPs) for the controlled delivery of the chemotherapeutic doxorubicin (IONP) to amplify the cytotoxicity of...
3.
Gilbert A, Tudor M, Delaunay A, Leman R, Levilly J, Atkinson A, et al.
Biomolecules
. 2024 Sep;
14(9).
PMID: 39334838
Chondrosarcoma is a rare malignant tumor that forms in bone and cartilage. The primary treatment involves surgical removal of the tumor with a margin of healthy tissue. Especially if complete...
4.
Negoita R, Ilisanu M, Irimescu I, Popescu R, Tudor M, Mihailescu M, et al.
Heliyon
. 2024 Aug;
10(15):e35249.
PMID: 39170121
Advances in radiotherapy, particularly the exploration of alternative radiation types such as carbon ions have updated our understanding of its effects and applicability on chondrosarcoma cells. Here we compare the...
5.
Tudor M, Popescu R, Negoita R, Gilbert A, Ilisanu M, Temelie M, et al.
Sci Rep
. 2023 Sep;
13(1):14878.
PMID: 37689817
New therapeutic approaches are needed for the management of the highly chemo- and radioresistant chondrosarcoma (CHS). In this work, we used polyethylene glycol-encapsulated iron oxide nanoparticles for the intracellular delivery...
6.
Gilbert A, Tudor M, Montanari J, Commenchail K, Savu D, Lesueur P, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046623
Chondrosarcoma is a malignant cartilaginous tumor that is particularly chemoresistant and radioresistant to X-rays. The first line of treatment is surgery, though this is almost impossible in some specific locations....
7.
Tudor M, Gilbert A, Lepleux C, Temelie M, Hem S, Armengaud J, et al.
Int J Mol Sci
. 2021 Aug;
22(15).
PMID: 34360718
Besides the direct effects of radiations, indirect effects are observed within the surrounding non-irradiated area; irradiated cells relay stress signals in this close proximity, inducing the so-called radiation-induced bystander effect....
8.
Thariat J, Valable S, Laurent C, Haghdoost S, Peres E, Bernaudin M, et al.
Int J Mol Sci
. 2019 Dec;
21(1).
PMID: 31878191
The resistance of cancer cells to radiotherapy is a major issue in the curative treatment of cancer patients. This resistance can be intrinsic or acquired after irradiation and has various...